Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fearon

Showing results (161-170 of 188) with videos related to

Pageof 19
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2006
CD27 mediates interleukin-2-independent clonal expansion of the CD8+ T cell without effector differentiationJames M Carr, Marlene J Carrasco, James E D Thaventhiran, et al.
The Journal of Infectious Diseases|April 1, 1993
Human anti-endotoxin antibody HA-1A mediates complement-dependent binding of Escherichia coli J5 lipopolysaccharide to complement receptor type 1 of human erythrocytes and neutrophilsJ I Krieger, R C Fletcher, S A Siegel, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1986
Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complementJ J Weis, D T Fearon, L B Klickstein, et al.
Transactions of the Association of American Physicians|January 1, 1990
Recombinant soluble CR1 suppressed complement activation, inflammation, and necrosis associated with reperfusion of ischemic myocardiumH F Weisman, T Bartow, M K Leppo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 25, 2012
Maintenance of T cell function in the face of chronic antigen stimulation and repeated reactivation for a latent virus infectionLaura K Mackay, Linda Wakim, Catherine J van Vliet, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2025
Signal peptide-independent secretion of keratin-19 by pancreatic cancer cellsPhilip Moresco, Jonathan P Kastan, Jung-In Yang, et al.
The Journal of Experimental Medicine|March 1, 1989
Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like alleleW W Wong, J M Cahill, M D Rosen, et al.
Science (New York, N.Y.)|July 13, 1990
Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosisH F Weisman, T Bartow, M K Leppo, et al.
Science (New York, N.Y.)|May 19, 2018
Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastasesArnaud Pommier, Naishitha Anaparthy, Nicoletta Memos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectorsA L Tutt, R R French, T M Illidge, et al.
Pageof 19

Showing results (161-170 of 188) with videos related to

Sort By:
Pageof 19
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2006
CD27 mediates interleukin-2-independent clonal expansion of the CD8+ T cell without effector differentiationJames M Carr, Marlene J Carrasco, James E D Thaventhiran, et al.
The Journal of Infectious Diseases|April 1, 1993
Human anti-endotoxin antibody HA-1A mediates complement-dependent binding of Escherichia coli J5 lipopolysaccharide to complement receptor type 1 of human erythrocytes and neutrophilsJ I Krieger, R C Fletcher, S A Siegel, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1986
Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complementJ J Weis, D T Fearon, L B Klickstein, et al.
Transactions of the Association of American Physicians|January 1, 1990
Recombinant soluble CR1 suppressed complement activation, inflammation, and necrosis associated with reperfusion of ischemic myocardiumH F Weisman, T Bartow, M K Leppo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 25, 2012
Maintenance of T cell function in the face of chronic antigen stimulation and repeated reactivation for a latent virus infectionLaura K Mackay, Linda Wakim, Catherine J van Vliet, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2025
Signal peptide-independent secretion of keratin-19 by pancreatic cancer cellsPhilip Moresco, Jonathan P Kastan, Jung-In Yang, et al.
The Journal of Experimental Medicine|March 1, 1989
Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like alleleW W Wong, J M Cahill, M D Rosen, et al.
Science (New York, N.Y.)|July 13, 1990
Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosisH F Weisman, T Bartow, M K Leppo, et al.
Science (New York, N.Y.)|May 19, 2018
Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastasesArnaud Pommier, Naishitha Anaparthy, Nicoletta Memos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectorsA L Tutt, R R French, T M Illidge, et al.
Pageof 19